Novartis AG (NVSEF) Stock Overview
Explore Novartis AG’s financial performance, market position, analyst ratings, and future outlook.
Novartis AG (NVSEF)
Key Financials
Key Financials
Market Cap
276.4B
P/E Ratio
21.05
EPS (TTM)
$6.98
ROE
0.32%
NVSEF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Novartis AG (NVSEF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 47.76, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $160.27.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.05 and a market capitalization of 276.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.